By further analyzing these overlapping DMRs, we observed DNA methylation changes in extracellular matrix components and organization, O-glycan processing, and intracellular factors including KRAS signaling and lipid and glucose metabolism, all pathways that may enhance the CRC risk in obesity. The gene discussed is KRAS; the disease is colorectal carcinoma.